Bonus Biogroup (Israel) Price Prediction
| BONS Stock | ILS 10.80 0.10 0.93% |
Oversold Vs Overbought
35
Oversold | Overbought |
Using Bonus Biogroup hype-based prediction, you can estimate the value of Bonus Biogroup from the perspective of Bonus Biogroup response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Bonus Biogroup to buy its stock at a price that has no basis in reality. In that case, they are not buying Bonus because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Bonus Biogroup after-hype prediction price | ILA 10.8 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Bonus |
Bonus Biogroup After-Hype Price Prediction Density Analysis
As far as predicting the price of Bonus Biogroup at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Bonus Biogroup or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Bonus Biogroup, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Bonus Biogroup Estimiated After-Hype Price Volatility
In the context of predicting Bonus Biogroup's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Bonus Biogroup's historical news coverage. Bonus Biogroup's after-hype downside and upside margins for the prediction period are 8.79 and 12.81, respectively. We have considered Bonus Biogroup's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Bonus Biogroup is not too volatile at this time. Analysis and calculation of next after-hype price of Bonus Biogroup is based on 3 months time horizon.
Bonus Biogroup Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Bonus Biogroup is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Bonus Biogroup backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Bonus Biogroup, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.53 | 2.01 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
10.80 | 10.80 | 0.00 |
|
Bonus Biogroup Hype Timeline
Bonus Biogroup is currently traded for 10.80on Tel Aviv Stock Exchange of Israel. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Bonus is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at -0.53%. %. The volatility of related hype on Bonus Biogroup is about 0.0%, with the expected price after the next announcement by competition of 10.80. About 50.0% of the company shares are held by company insiders. The book value of Bonus Biogroup was currently reported as 0.12. The company recorded a loss per share of 0.08. Bonus Biogroup had not issued any dividends in recent years. The entity had 1:10 split on the 3rd of June 2012. Assuming the 90 days trading horizon the next forecasted press release will be in 5 to 10 days. Check out Bonus Biogroup Basic Forecasting Models to cross-verify your projections.Bonus Biogroup Related Hype Analysis
Having access to credible news sources related to Bonus Biogroup's direct competition is more important than ever and may enhance your ability to predict Bonus Biogroup's future price movements. Getting to know how Bonus Biogroup's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Bonus Biogroup may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| BEZQ | Bezeq Israeli Telecommunication | 0.00 | 0 per month | 1.32 | 0.08 | 3.25 | (2.35) | 8.84 | |
| ELAL | El Al Israel | 0.00 | 0 per month | 3.84 | 0.12 | 5.04 | (6.13) | 15.23 | |
| LUMI | Bank Leumi Le Israel | 0.00 | 0 per month | 1.30 | 0.15 | 2.58 | (2.60) | 6.40 | |
| ESLT | Elbit Systems | 0.00 | 0 per month | 0.87 | 0.15 | 4.09 | (2.03) | 8.80 | |
| TSEM | Tower Semiconductor | 0.00 | 0 per month | 2.75 | 0.01 | 3.91 | (3.61) | 14.22 |
Bonus Biogroup Additional Predictive Modules
Most predictive techniques to examine Bonus price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Bonus using various technical indicators. When you analyze Bonus charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Bonus Biogroup Predictive Indicators
The successful prediction of Bonus Biogroup stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Bonus Biogroup, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Bonus Biogroup based on analysis of Bonus Biogroup hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Bonus Biogroup's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Bonus Biogroup's related companies.
Story Coverage note for Bonus Biogroup
The number of cover stories for Bonus Biogroup depends on current market conditions and Bonus Biogroup's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Bonus Biogroup is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Bonus Biogroup's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Bonus Biogroup Short Properties
Bonus Biogroup's future price predictability will typically decrease when Bonus Biogroup's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Bonus Biogroup often depends not only on the future outlook of the potential Bonus Biogroup's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bonus Biogroup's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.2 B |
Complementary Tools for Bonus Stock analysis
When running Bonus Biogroup's price analysis, check to measure Bonus Biogroup's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bonus Biogroup is operating at the current time. Most of Bonus Biogroup's value examination focuses on studying past and present price action to predict the probability of Bonus Biogroup's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bonus Biogroup's price. Additionally, you may evaluate how the addition of Bonus Biogroup to your portfolios can decrease your overall portfolio volatility.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Stocks Directory Find actively traded stocks across global markets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |